Creative Planning’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$848K Buy
18,355
+2,890
+19% +$117K ﹤0.01% 2785
2026
Q1
$512K Sell
15,465
-1,733
-10% -$56.3K ﹤0.01% 3012
2025
Q4
$563K Buy
17,198
+721
+4% +$17.7K ﹤0.01% 2736
2025
Q3
$294K Sell
16,477
-4,886
-23% -$70.9K ﹤0.01% 3163
2025
Q2
$232K Sell
21,363
-4,362
-17% -$57.1K ﹤0.01% 3109
2025
Q1
$476K Buy
25,725
+706
+3% +$12.7K ﹤0.01% 2331
2024
Q4
$412K Sell
25,019
-4,771
-16% -$67.6K ﹤0.01% 2405
2024
Q3
$418K Buy
29,790
+17,980
+152% +$199K ﹤0.01% 2265
2024
Q2
$85.5K Buy
+11,810
New +$80.7K ﹤0.01% 2872
2023
Q4
Sell
-18,908
Closed -$94.5K 2775
2023
Q3
$94.5K Buy
+18,908
New +$131K ﹤0.01% 2403
2022
Q2
Sell
-4,000
Closed -$32K 2290
2022
Q1
$32K Buy
+4,000
New +$34.5K ﹤0.01% 2097

Other funds holding AXGN

Creative Planning's AXGN Position: Q2 2026 in Review

Creative Planning increased its Axogen (AXGN) stake by 19% in Q2 2026, buying an estimated $117K and bringing the position to 18,355 shares worth $848K. The position accounts for ﹤0.01% of the portfolio, ranked #2785.

Creative Planning first reported a position in AXGN in Q1 2022 and has held it in 11 quarters since. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Creative Planning held 18,355 shares of Axogen worth $848K as of Q2 2026.
  • Creative Planning bought 2,890 Axogen shares in Q2 2026, an estimated $117K.
  • Axogen made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #2785 holding.
  • Creative Planning first reported a position in Axogen in Q1 2022 and has held it in 11 quarters since.
  • 254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.